Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in
J
apanese patients with type 2 diabetes: a randomized, open‐label, phase
III
, non‐inferiority study
2015 ◽
Vol 17
(10)
◽
pp. 994-1002
◽
Keyword(s):